Andrew J. Last - Net Worth and Insider Trading

Andrew J. Last Net Worth

The estimated net worth of Andrew J. Last is at least $3 Million dollars as of 2024-04-19. Andrew J. Last is the EVP, COO of Affymetrix Inc and owns about 170,112 shares of Affymetrix Inc (AFFX) stock worth over $2 Million. Andrew J. Last is the EVP, COO of Bio-Rad Laboratories Inc and owns about 1,736 shares of Bio-Rad Laboratories Inc (BIO) stock worth over $484,231. Andrew J. Last is also the Director of OncoCyte Corp and owns about 3,509 shares of OncoCyte Corp (OCX) stock worth over $8,737. Besides these, Andrew J. Last also holds Precigen Inc (PGEN) . Details can be seen in Andrew J. Last's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew J. Last has not made any transactions after 2022-08-17 and currently still holds the listed stock(s).

Transaction Summary of Andrew J. Last

To

Andrew J. Last Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew J. Last owns 4 companies in total, including Bio-Rad Laboratories Inc (BIO) , OncoCyte Corp (OCX) , and Precigen Inc (PGEN) among others .

Click here to see the complete history of Andrew J. Last’s form 4 insider trades.

Insider Ownership Summary of Andrew J. Last

Ticker Comapny Transaction Date Type of Owner
BIO Bio-Rad Laboratories Inc 2021-04-29 EVP & Chief Operating Officer
OCX OncoCyte Corp 2022-08-17 director
PGEN Precigen Inc 2017-11-13 Chief Operating Officer
AFFX Affymetrix Inc 2016-03-31 EVP & Chief Operating Officer

Andrew J. Last Latest Holdings Summary

Andrew J. Last currently owns a total of 4 stocks. Among these stocks, Andrew J. Last owns 170,112 shares of Affymetrix Inc (AFFX) as of March 25, 2015, with a value of $2 Million and a weighting of 82.71%. Andrew J. Last owns 1,736 shares of Bio-Rad Laboratories Inc (BIO) as of September 1, 2021, with a value of $484,231 and a weighting of 16.8%. Andrew J. Last also owns 3,509 shares of OncoCyte Corp (OCX) as of August 17, 2022, with a value of $8,737 and a weighting of 0.3%. The other 1 stocks Precigen Inc (PGEN) have a combined weighting of 0.18% among all his current holdings.

Latest Holdings of Andrew J. Last

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AFFX Affymetrix Inc 2015-03-25 170,112 14.01 2,383,269
BIO Bio-Rad Laboratories Inc 2021-09-01 1,736 278.94 484,231
OCX OncoCyte Corp 2022-08-17 3,509 2.49 8,737
PGEN Precigen Inc 2017-11-13 4,000 1.32 5,280

Holding Weightings of Andrew J. Last


Andrew J. Last Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew J. Last has made a total of 0 transactions in Affymetrix Inc (AFFX) over the past 5 years. The most-recent trade in Affymetrix Inc is the sale of 110,000 shares on March 25, 2015, which brought Andrew J. Last around $1 Million.

According to the SEC Form 4 filings, Andrew J. Last has made a total of 1 transactions in Bio-Rad Laboratories Inc (BIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bio-Rad Laboratories Inc is the sale of 2,000 shares on September 1, 2021, which brought Andrew J. Last around $2 Million.

According to the SEC Form 4 filings, Andrew J. Last has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 1,000 shares on August 17, 2022, which cost Andrew J. Last around $17,400.

More details on Andrew J. Last's insider transactions can be found in the Insider Trading History of Andrew J. Last table.

Insider Trading History of Andrew J. Last

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew J. Last Trading Performance

GuruFocus tracks the stock performance after each of Andrew J. Last's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew J. Last is -12.58%. GuruFocus also compares Andrew J. Last's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew J. Last within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew J. Last's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew J. Last

Average Return

-17.79%

Average return per transaction

Outperforming Transactions

33%

2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.19 -12.58 -2.62 -17.79 -4.88 2.78
Relative Return to S&P 500(%) 6.76 -17.17 -13.47 -30.4 -19.39 -11.74

Andrew J. Last Ownership Network

Ownership Network List of Andrew J. Last

No Data

Ownership Network Relation of Andrew J. Last


Andrew J. Last Owned Company Details

What does Bio-Rad Laboratories Inc do?

Who are the key executives at Bio-Rad Laboratories Inc?

Andrew J. Last is the EVP & Chief Operating Officer of Bio-Rad Laboratories Inc. Other key executives at Bio-Rad Laboratories Inc include INT PRIN ACCTG OFC Tania Devilliers , EVP & Global Supply Chain Sedat Evran , and EVP & Global Human Resources Corey Colleen .

Bio-Rad Laboratories Inc (BIO) Insider Trades Summary

Over the past 18 months, Andrew J. Last made no insider transaction in Bio-Rad Laboratories Inc (BIO). Other recent insider transactions involving Bio-Rad Laboratories Inc (BIO) include a net sale of 6,896 shares made by Timothy S Ernst , a net sale of 3,642 shares made by Michael Crowley , and a net sale of 577 shares made by Ajit Ramalingam .

In summary, during the past 3 months, insiders sold 5,500 shares of Bio-Rad Laboratories Inc (BIO) in total and bought 0 shares, with a net sale of 5,500 shares. During the past 18 months, 12,315 shares of Bio-Rad Laboratories Inc (BIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,315 shares.

Bio-Rad Laboratories Inc (BIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bio-Rad Laboratories Inc Insider Transactions

No Available Data

Andrew J. Last Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew J. Last. You might contact Andrew J. Last via mailing address: 3420 Central Expressway, Santa Clara Ca 95051.

Discussions on Andrew J. Last

No discussions yet.